TTK Healthcare [TTKHLTCARE] vs Cipla [CIPLA] Detailed Stock Comparison

TTK Healthcare Ltd

NSE
Loading...

Cipla Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: TTK Healthcare Ltd wins in 5 metrics, Cipla Ltd. wins in 15 metrics, with 0 ties. Cipla Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric TTK Healthcare Ltd Cipla Ltd. Better
P/E Ratio (TTM) 21.64 23.20 TTK Healthcare Ltd
Price-to-Book Ratio 1.20 3.20 TTK Healthcare Ltd
Debt-to-Equity Ratio 2.47 1.42 Cipla Ltd.
PEG Ratio -0.56 -0.48 Cipla Ltd.
EV/EBITDA 32.88 14.99 Cipla Ltd.
Profit Margin (TTM) 7.24% 16.26% Cipla Ltd.
Operating Margin (TTM) 2.35% 14.03% Cipla Ltd.
EBITDA Margin (TTM) 2.35% 14.03% Cipla Ltd.
Return on Equity 7.67% 16.85% Cipla Ltd.
Return on Assets (TTM) 6.37% 14.10% Cipla Ltd.
Free Cash Flow (TTM) $-168.16M $34.57B Cipla Ltd.
Dividend Yield 0.74% 1.72% Cipla Ltd.
1-Year Return -30.05% -7.69% Cipla Ltd.
Price-to-Sales Ratio (TTM) 1.57 3.77 TTK Healthcare Ltd
Enterprise Value $7.42B $954.58B Cipla Ltd.
EV/Revenue Ratio 0.89 3.41 TTK Healthcare Ltd
Gross Profit Margin (TTM) 53.36% 62.20% Cipla Ltd.
Revenue per Share (TTM) $587 $346 TTK Healthcare Ltd
Earnings per Share (Diluted) $42.53 $56.28 Cipla Ltd.
Beta (Stock Volatility) 0.17 0.06 Cipla Ltd.

TTK Healthcare Ltd vs Cipla Ltd. Stock Performance Analysis

Loading Price Chart...

TTKHLTCARE
CIPLA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TTK Healthcare Ltd-1.45%-2.04%-2.14%6.84%-16.44%-14.48%
Cipla Ltd.-0.53%-0.42%-3.49%6.32%-8.35%-7.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TTK Healthcare Ltd-30.05%-29.39%43.44%-3.20%117.54%214.14%
Cipla Ltd.-7.69%38.10%44.59%185.62%323.08%558.95%

Performance & Financial Health Analysis: TTK Healthcare Ltd vs Cipla Ltd.

MetricTTKHLTCARECIPLA
Market Information
Market Cap i₹13.01B₹1.06T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,4302,059,161
90 Day Avg. Volume i7,6521,842,417
Last Close₹878.15₹1,382.10
52 Week Range₹735.00 - ₹1,398.90₹1,165.70 - ₹1,673.00
% from 52W High-37.23%-17.39%
All-Time High₹1,893.95 (Sep 09, 2024)₹1,673.00 (Oct 23, 2025)
% from All-Time High-53.63%-17.39%
Growth Metrics
Quarterly Revenue Growth0.02%0.02%
Quarterly Earnings Growth-0.37%-0.57%
Financial Health
Profit Margin (TTM) i0.07%0.16%
Operating Margin (TTM) i0.02%0.14%
Return on Equity (TTM) i0.08%0.17%
Debt to Equity (MRQ) i2.471.42
Cash & Liquidity
Book Value per Share (MRQ)₹768.05₹407.53
Cash per Share (MRQ)₹425.03₹131.25
Operating Cash Flow (TTM) i₹338.96M₹55.16B
Levered Free Cash Flow (TTM) i₹816.57M₹52.73B
Dividends
Last 12-Month Dividend Yield i0.74%1.72%
Last 12-Month Dividend i₹10.00₹26.00

Valuation & Enterprise Metrics Analysis: TTK Healthcare Ltd vs Cipla Ltd.

MetricTTKHLTCARE (Apr 26, 2026)CIPLA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i21.6423.20
Forward P/E iN/A23.62
PEG Ratio i-0.56-0.48
Price to Sales (TTM) i1.573.77
Price to Book (MRQ) i1.203.20
Market Capitalization
Market Capitalization i₹13.01B₹1.06T
Enterprise Value i₹7.42B₹954.58B
Enterprise Value Metrics
Enterprise to Revenue i0.893.41
Enterprise to EBITDA i32.8814.99
Risk & Other Metrics
Beta i0.170.06
Book Value per Share (MRQ) i₹768.05₹407.53

Financial Statements Comparison: TTK Healthcare Ltd vs Cipla Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTTKHLTCARE (2025)CIPLA (2025)
Revenue/Sales i7.98B271.45B
Cost of Goods Sold i3.72B97.63B
COGS % of Revenue i46.6%36.0%
Gross Profit i4.26B173.83B
Gross Margin i53.4%64.0%
Research & Development i1.64M3.76B
Operating Income (EBIT) i269.33M61.44B
Operating Margin i3.4%22.6%
EBITDA i1.05B74.32B
EBITDA Margin i13.2%27.4%
Pre-Tax Income i1.08B68.21B
Pre-Tax Income % of Revenue i13.6%25.1%
Income Tax i266.75M15.30B
Income Tax % of Revenue i3.3%5.6%
Net Income (Profit) i816.57M52.69B
Profit Margin i10.2%19.4%

Balance Sheet & Liquidity Metrics

MetricTTKHLTCARE (2025)CIPLA (2025)
Cash & Equivalents i90.06M5.89B
Total Current Assets i11.04B232.89B
Total Current Assets % of Revenue i138.4%85.8%
Total Current Liabilities i2.11B54.84B
Total Current Liabilities % of Revenue i26.4%20.2%
Long-Term Debt i17.73M2.52B
Long-Term Debt % of Revenue i0.2%0.9%
Total Shareholders Equity i10.65B312.89B
Retained Earnings i9.40B256.44B
Retained Earnings % of Revenue i117.9%94.5%
Property, Plant & Equipment i808.99M52.62B

Cash Flow Statement Comparison

MetricTTKHLTCARE (2025)CIPLA (2025)
Operating Cash Flow i338.96M55.16B
Operating Cash Flow % of Revenue i4.2%20.3%
Capital Expenditures i104.56M-11.37B
Free Cash Flow i-168.16M34.57B
FCF Margin i-2.1%12.7%
Debt Repayment iN/A-980.10M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTTKHLTCARECIPLA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.13M807.78M
Float Shares i3.25M563.37M
% Held by Insiders i75.64%30.96%
% Held by Institutions i1.89%40.34%
% Held by Public i22.47%28.70%

Dividend Analysis & Yield Comparison: TTK Healthcare Ltd vs Cipla Ltd.

MetricTTKHLTCARECIPLA
Last 12-Month Dividend i₹10.00₹26.00
Last 12-Month Dividend Yield i0.74%1.72%
3-Year Avg Annual Dividend i₹13.33₹16.00
3-Year Avg Dividend Yield i0.85%0.76%
3-Year Total Dividends i₹40.00₹48.00
Ex-Dividend DateJul 18, 2025Jun 27, 2025